These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
658 related items for PubMed ID: 28437788
21. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216 [Abstract] [Full Text] [Related]
22. Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome. Zore T, Lizneva D, Brakta S, Walker W, Suturina L, Azziz R. Fertil Steril; 2019 Feb; 111(2):389-396. PubMed ID: 30527835 [Abstract] [Full Text] [Related]
23. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. Ibáñez L, López-Bermejo A, Díaz M, Marcos MV, de Zegher F. J Clin Endocrinol Metab; 2011 Aug; 96(8):E1262-7. PubMed ID: 21632811 [Abstract] [Full Text] [Related]
24. Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. Codner E, Escobar-Morreale HF. J Clin Endocrinol Metab; 2007 Apr; 92(4):1209-16. PubMed ID: 17284617 [Abstract] [Full Text] [Related]
25. How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities. Wang YY, Li SW, Luo S, Qin L, Zeng X, Li L, Li XH. Biomed Res Int; 2019 Apr; 2019():6126808. PubMed ID: 30854398 [Abstract] [Full Text] [Related]
26. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis. Bayona A, Martínez-Vaello V, Zamora J, Nattero-Chávez L, Luque-Ramírez M, Escobar-Morreale HF. Hum Reprod Update; 2022 Jun 30; 28(4):501-517. PubMed ID: 35237802 [Abstract] [Full Text] [Related]
27. [Diagnosing polycystic ovary syndrome in adolescent girls]. Drosdzol-Cop A, Sidło-Stawowy A, Sajdak D, Skrzypulec-Plinta V. Ginekol Pol; 2014 Feb 30; 85(2):145-8. PubMed ID: 24745161 [Abstract] [Full Text] [Related]
28. Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome. Leerasiri P, Wongwananuruk T, Indhavivadhana S, Techatraisak K, Rattanachaiyanont M, Angsuwathana S. J Obstet Gynaecol Res; 2016 Jun 30; 42(6):678-83. PubMed ID: 26890011 [Abstract] [Full Text] [Related]
29. Prevalence of Polycystic Ovarian Syndrome in Girls with a History of Idiopathic Central Precocious Puberty. Arcari AJ, Freire AV, Ballerini MG, Escobar ME, Díaz Marsiglia YM, Bergadá I, Ropelato MG, Gryngarten MG. Horm Res Paediatr; 2024 Jun 30; 97(2):134-139. PubMed ID: 37552972 [Abstract] [Full Text] [Related]
30. [Rotterdam consensus in adolescent girls: which investigations and how to interpret them to make the diagnosis of PCOS?]. Reyss AC, Proust-Richard C, Catteau-Jonard S, Dewailly D. Gynecol Obstet Fertil; 2006 Apr 30; 34(4):341-6. PubMed ID: 16630737 [Abstract] [Full Text] [Related]
31. Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis. Escobar-Morreale HF, Roldán-Martín MB. Diabetes Care; 2016 Apr 30; 39(4):639-48. PubMed ID: 27208367 [Abstract] [Full Text] [Related]
32. Do Different Diagnostic Criteria Impact Polycystic Ovary Syndrome Diagnosis for Adolescents? Akgül S, Düzçeker Y, Kanbur N, Derman O. J Pediatr Adolesc Gynecol; 2018 Jun 30; 31(3):258-262. PubMed ID: 29233731 [Abstract] [Full Text] [Related]
33. The Diagnostic Value of Anti-Müllerian Hormone in Early Post Menarche Adolescent Girls with Polycystic Ovarian Syndrome. Kocaay P, Siklar Z, Buyukfirat S, Berberoglu M. J Pediatr Adolesc Gynecol; 2018 Aug 30; 31(4):362-366. PubMed ID: 29462707 [Abstract] [Full Text] [Related]
34. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index. Bizzarri C, Benevento D, Ravà L, Patera IP, Schiaffini R, Ciampalini P, Giannone G, Cappa M. Fertil Steril; 2011 Dec 30; 96(6):1497-1502.e1. PubMed ID: 21982726 [Abstract] [Full Text] [Related]
35. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study. Koch T, Doherty DA, Dickinson JE, Juul A, Hart R, Bräuner EV, Hickey M. Psychoneuroendocrinology; 2021 Mar 30; 125():105104. PubMed ID: 33352473 [Abstract] [Full Text] [Related]
36. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study. Skiba MA, Bell RJ, Herbert D, Garcia AM, Islam RM, Davis SR. Hum Reprod; 2021 May 17; 36(6):1611-1620. PubMed ID: 33846715 [Abstract] [Full Text] [Related]
37. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. BJOG; 2006 Oct 17; 113(10):1210-7. PubMed ID: 16972863 [Abstract] [Full Text] [Related]
38. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F. Eur J Obstet Gynecol Reprod Biol; 2014 Mar 17; 174():100-5. PubMed ID: 24411130 [Abstract] [Full Text] [Related]
39. Different pregnancy outcomes according to the polycystic ovary syndrome diagnostic criteria: a systematic review and meta-analysis of 79 studies. Chatzakis C, Tsakmaki E, Psomiadou A, Charitakis N, Eleftheriades M, Dinas K, Goulis D, Sotiriadis A. Fertil Steril; 2022 Apr 17; 117(4):854-881. PubMed ID: 35120743 [Abstract] [Full Text] [Related]
40. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty. Otto-Buczkowska E, Grzyb K, Jainta N. Pediatr Endocrinol Diabetes Metab; 2018 Apr 17; 24(1):40-44. PubMed ID: 30083660 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]